Releases, publications, achievements
July'20
The company received a Marketing authorization for VivoSpiro MVS-0 digital inhaler.
On 13 July, 2020, our company received a Marketing authorization for VivoSpiro MVS-01 inhaler (No. РЗН 2020/11140). In the near future, we are planning to start official deliveries to anti-tuberculosis medical facilities.

March'19
Our company's representatives took part in the 13th Scientific Symposium on World Tuberculosis Day 2019.
On 20 March, 2018, Berlin, a "New developments, nanotechnology" section was held, organized by our company, as part of the 13th Scientific Symposium on the occasion of World Tuberculosis Day 2019. The section discussed the introduction of PM&HM technologies in the treatment of tuberculosis in the world.

September'18
Our company's representatives took part in the UN General Assembly dedicated to the fight against tuberculosis.
Director General Oleg Abdiev and Development Director Anton Melnikov took part in the 73rd session of the UN General Assembly in New York. During the session, meetings were held with representatives of the international expert community. The experts supported the project and stated the need for further development of technologies in the world for the treatment of tuberculosis and other diseases.